-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Lakefront Biotherapeutics, Lowers Price Target to $26

Benzinga·08/11/2026 15:20:32
Listen to the news
RBC Capital analyst Brian Abrahams maintains Lakefront Biotherapeutics (NASDAQ:LKFT) with a Sector Perform and lowers the price target from $28 to $26.